KONINKLIJKE PHILIPS NV (PHIA.AS) Fundamental Analysis & Valuation

AMS:PHIA • NL0000009538

Current stock price

24.4 EUR
-0.42 (-1.69%)
Last:

This PHIA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. PHIA.AS Profitability Analysis

1.1 Basic Checks

  • PHIA had positive earnings in the past year.
  • PHIA had a positive operating cash flow in the past year.
  • In multiple years PHIA reported negative net income over the last 5 years.
  • PHIA had a positive operating cash flow in 4 of the past 5 years.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • With a Return On Assets value of 3.32%, PHIA perfoms like the industry average, outperforming 47.54% of the companies in the same industry.
  • PHIA's Return On Equity of 8.17% is fine compared to the rest of the industry. PHIA outperforms 60.66% of its industry peers.
  • With a Return On Invested Capital value of 5.50%, PHIA perfoms like the industry average, outperforming 50.82% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for PHIA is significantly below the industry average of 10.31%.
  • The 3 year average ROIC (3.48%) for PHIA is below the current ROIC(5.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.5%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • PHIA has a Profit Margin of 5.02%. This is comparable to the rest of the industry: PHIA outperforms 47.54% of its industry peers.
  • PHIA's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 7.98%, PHIA perfoms like the industry average, outperforming 45.90% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PHIA has declined.
  • PHIA has a Gross Margin of 45.18%. This is in the lower half of the industry: PHIA underperforms 75.41% of its industry peers.
  • PHIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PHIA.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHIA is destroying value.
  • The number of shares outstanding for PHIA has been increased compared to 1 year ago.
  • The number of shares outstanding for PHIA has been increased compared to 5 years ago.
  • Compared to 1 year ago, PHIA has a worse debt to assets ratio.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • PHIA has an Altman-Z score of 2.03. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • PHIA has a Altman-Z score of 2.03. This is in the lower half of the industry: PHIA underperforms 60.66% of its industry peers.
  • PHIA has a debt to FCF ratio of 16.37. This is a negative value and a sign of low solvency as PHIA would need 16.37 years to pay back of all of its debts.
  • PHIA has a Debt to FCF ratio (16.37) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.63 indicates that PHIA is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.63, PHIA is not doing good in the industry: 68.85% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z 2.03
ROIC/WACC0.88
WACC6.24%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • PHIA has a Current Ratio of 1.32. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of PHIA (1.32) is worse than 60.66% of its industry peers.
  • A Quick Ratio of 0.94 indicates that PHIA may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.94, PHIA is doing worse than 62.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PHIA.AS Growth Analysis

3.1 Past

  • PHIA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.11%.
  • PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.62% yearly.
  • The Revenue has decreased by -1.03% in the past year.
  • The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.24% on average per year.
  • The Revenue is expected to grow by 3.78% on average over the next years.
EPS Next Y3.11%
EPS Next 2Y8.19%
EPS Next 3Y10.16%
EPS Next 5Y10.24%
Revenue Next Year1.44%
Revenue Next 2Y2.95%
Revenue Next 3Y3.5%
Revenue Next 5Y3.78%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. PHIA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.60, the valuation of PHIA can be described as correct.
  • PHIA's Price/Earnings ratio is rather cheap when compared to the industry. PHIA is cheaper than 88.52% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of PHIA to the average of the S&P500 Index (27.71), we can say PHIA is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 16.10, which indicates a correct valuation of PHIA.
  • Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 67.21% of the companies are valued more expensively.
  • PHIA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.09.
Industry RankSector Rank
PE 16.6
Fwd PE 16.1
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 73.77% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 47.56
EV/EBITDA 11.45
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.33
PEG (5Y)N/A
EPS Next 2Y8.19%
EPS Next 3Y10.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHIA.AS Dividend Analysis

5.1 Amount

  • PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHIA.AS Fundamentals: All Metrics, Ratios and Statistics

KONINKLIJKE PHILIPS NV

AMS:PHIA (4/21/2026, 7:00:00 PM)

24.4

-0.42 (-1.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners48.33%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap23.50B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts74.67
Price Target28.96 (18.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.35
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)-1.22%
PT rev (3m)6.57%
EPS NQ rev (1m)-4.65%
EPS NQ rev (3m)-24.01%
EPS NY rev (1m)-0.89%
EPS NY rev (3m)-0.39%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-1.26%
Valuation
Industry RankSector Rank
PE 16.6
Fwd PE 16.1
P/S 1.32
P/FCF 47.56
P/OCF 20.22
P/B 2.14
P/tB N/A
EV/EBITDA 11.45
EPS(TTM)1.47
EY6.02%
EPS(NY)1.52
Fwd EY6.21%
FCF(TTM)0.51
FCFY2.1%
OCF(TTM)1.21
OCFY4.95%
SpS18.52
BVpS11.38
TBVpS-0.92
PEG (NY)5.33
PEG (5Y)N/A
Graham Number19.4007 (-20.49%)
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.5%
ROICexc 6.42%
ROICexgc 22.25%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
ROICexc(3y)3.99%
ROICexc(5y)N/A
ROICexgc(3y)13.73%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z 2.03
F-Score7
WACC6.24%
ROIC/WACC0.88
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y3.11%
EPS Next 2Y8.19%
EPS Next 3Y10.16%
EPS Next 5Y10.24%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.44%
Revenue Next 2Y2.95%
Revenue Next 3Y3.5%
Revenue Next 5Y3.78%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.02%
EBIT Next 3Y26.32%
EBIT Next 5Y17.86%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NV / PHIA.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


What is the valuation status for PHIA stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


What is the profitability of PHIA stock?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 4 / 10.


What is the financial health of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.


Can you provide the expected EPS growth for PHIA stock?

The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to grow by 3.11% in the next year.